Social Post
97.1% Patient Satisfaction
It's our goal to provide products and services that deliver exceptional results and prioritize your safety¹ and well-being.
Available for posting until October 1, 2026
Instagram Business
It's our goal to provide products and services that deliver exceptional results and prioritize your safety¹ and well-being. That’s where Motiva® breast implants come in!
🌟 97.1% of patients were satisfied with their results²*
💎 Less than 1% device-related complications¹,³
🌎 Trusted in over 86 countries, worldwide³
Link in bio 🔗 to schedule a consultation today.
#MotivaUSA #BreastImplants #MotivatedByMotiva
1. Establishment Labs® Holdings Corp. Establishment Labs® Notes Presentation of 4-Year Results from Motiva® U.S. IDE Study at The Aesthetic Meeting 2024. https://investors.establishmentlabs.com/press-releases/pressreleasesdetails/2024/Establishment-Labs-Notes-Presentation-of-4-Year-Results-from-Motiva-U.S.-IDEStudy-at-The-Aesthetic-Meeting-2024/default.aspx. Published May 2nd, 2024. Accessed May 28th, 2024.
2. Glicksman C, Wolfe A, McGuire P. The Study of the Safety and Effectiveness of Motiva SmoothSilk Silicone Gel-Filled Breast Implants in Patients Undergoing Primary and Revisional Breast Augmentation: Three-Year Clinical Data. Aesthet Surg J. 2024 Sep 27:sjae134. doi: 10.1093/asj/sjae134. Epub ahead of print. PMID: 39331509.
3. Establishment Labs®, Post-Market Surveillance Preliminary Results Q1 2024. Internal Data on File.
Available for posting until October 1, 2026
Instagram Business
It's our goal to provide products and services that deliver exceptional results and prioritize your safety¹ and well-being. That’s where Motiva® breast implants come in!
🌟 97.1% of patients were satisfied with their results²*
💎 Less than 1% device-related complications¹,³
🌎 Trusted in over 86 countries, worldwide³
Link in bio 🔗 to schedule a consultation today.
#MotivaUSA #BreastImplants #MotivatedByMotiva
1. Establishment Labs® Holdings Corp. Establishment Labs® Notes Presentation of 4-Year Results from Motiva® U.S. IDE Study at The Aesthetic Meeting 2024. https://investors.establishmentlabs.com/press-releases/pressreleasesdetails/2024/Establishment-Labs-Notes-Presentation-of-4-Year-Results-from-Motiva-U.S.-IDEStudy-at-The-Aesthetic-Meeting-2024/default.aspx. Published May 2nd, 2024. Accessed May 28th, 2024.
2. Glicksman C, Wolfe A, McGuire P. The Study of the Safety and Effectiveness of Motiva SmoothSilk Silicone Gel-Filled Breast Implants in Patients Undergoing Primary and Revisional Breast Augmentation: Three-Year Clinical Data. Aesthet Surg J. 2024 Sep 27:sjae134. doi: 10.1093/asj/sjae134. Epub ahead of print. PMID: 39331509.
3. Establishment Labs®, Post-Market Surveillance Preliminary Results Q1 2024. Internal Data on File.